Search Results:

Matching test names:

• D Dimer  (See: D-Dimer, Quantitative)
• D pteronyssinus (Mites)  (See: Allergen: Inhalants, Environmental Profile 10 - LG5471)
• D. Varnea (Mites)  (See: Allergen: Inhalants, Environmental Profile 10 - LG5471)
• D816V  (See: Next Generation Sequencing Oncology Tumor Testing)
• D835  (See: FLT3 Mutation Detection ITD/TKD by NGS)
• Dabigatran Level - LG5467
• Dabigatron Level - LG5467
• Darvon  (See: Propoxyphene)
• DAT  (See: Direct Antiglobulin Test, UMMC-University, Northland, Range and Grand Itasca Only)
• DAT Negative Hemolytic Anemia Workup - LG5612
• DAT/Elution  (See: Direct Antiglobulin Test)
• Date Rape Drug  (See: Flunitrazepam and Metabolites)
• Date Rape Drug  (See: Flunitrazepam Confirmation)
• Datril  (See: Acetaminophen to MedTox)
• Daucus Carota, F31  (See: Allergen: Carrot, IgE)
• DAX1 Duplication and Deletion  (See: NROB1 Gene Analysis)
• DAX1 Gene Sequencing  (See: NROB1 Gene Analysis)
• DCM  (See: Cardiomyopathy Gene Analysis)
• DCX  (See: Holoprosencephly Gene Evaluation)
• DD  (See: D-Dimer, Quantitative)
• dd-cfDNA  (See: AlloSure Kidney Transplant Monitoring)
• dd-cfDNA  (See: Prospera Transplant Assessment)
• DDD  (See: C3G Functional Panel - LG6785)
• D-desoxyephedrine  (See: Methamphetamine)
• D-Dimer, Quantitative
• D-Dimer, Quantitative
• Deamidated Gliadin Antibodies, IgA and IgG
• Deamidated Gliadin Peptide Antibodies  (See: Deamidated Gliadin Antibodies, IgA and IgG)
• DEB Test  (See: Chromosome Analysis, Blood, Fanconi Mutagen Sensitivity Study)
• Decipher Prostate Cancer Classifier - LG6369
• DecodEX Level 2 - LG6520
• Decoy Cells  (See: Cytology, Urinary Tract)
• Dehydroepiandrosterone
• Dehydroepiandrosterone Sulfate  (See: DHEA Sulfate)
• Deletion and Duplication  (See: Osteopetrosis Gene Sequencing)
• Deletion and Duplication  (See: Hereditary Hemorrhagic Telangiectasia (ACVR1 and ENG) Sequencing and Deletion/Duplication)
• Deletion and Duplication  (See: Holoprosencephly Gene Evaluation)
• Deletion and Duplication  (See: PHOX2B Gene Sequencing)
• Deletion and Duplication  (See: Hereditary Pressure Palsy Neuropathy)
• Deletion and Duplication  (See: Next Generation Sequencing)
• Deletion and Duplication  (See: Gaucher Disease Mutation Analysis)
• Deletion and Duplication  (See: ALDOB Gene Sequencing)
• Deletion and Duplication  (See: Epidermolysis Bullosa Gene Analysis)
• Deletion and Duplication  (See: Chronic Granulomatous Gene Analysis)
• Deletion and Duplication  (See: Ichthyosis Gene Analysis)
• Delta-Aminolevulinic Acid, Urine  (See: Aminolevulinic Acid (ALA), Urine)
• Dementia Auto-Immune Evaluation, CSF - Cancel and reorder as MMMISC - LG6465
• Dementia Auto-Immune Evaluation, CSF - LG6465
• Demerol  (See: Meperidine and Normeperidine, Urine)
• Demerol  (See: Meperidine and Normeperidine)
• Demyelinating Charcot Marie Tooth  (See: Charcot Marie Tooth (CMT) Evaluation)
• Demyelinating Neuropathy Panel - LG5484
• Dengue Fever Antibody, IgG and IgM
• Dentatorubrapallidotuysian Atrophy  (See: DRPLA (ATN1) Repeat Expansion DNA Test)
• Deoxycholic Acid  (See: Bile Acids, Fractionated and Total)
• Deoxycorticosterone, LC/MS/MS 90973 - LG5323
• Deoxycorticosterone, Pediatric
• Deoxycortisol  (See: 11-Deoxycortisol, Quantitative by HPLC-MS/MS, Serum or Plasma)
• Deoxycortisol  (See: 11-Deoxycortisol, Pediatric)
• Deoxypyridinoline Crosslinks, Urine
• Depakene  (See: Valproic Acid)
• Depakene  (See: Valproic Acid, Grand Itasca)
• Depakote  (See: Valproic Acid)
• Depakote  (See: Valproic Acid, Grand Itasca)
• Derm  (See: Dermatopathology)
• Derm Path  (See: Dermatopathology)
• Dermatomyositis and Polymyositis Panel
• Dermatomyositis Autoantibody Panel
• Dermatomyositis Panel
• Dermatopathology
• Dermatophyte  (See: KOH Skin, Hair or Nails)
• Dermatophyte  (See: KOH Skin, Hair or Nails, Range)
• Dermatophyte Culture  (See: Fungus Skin, Hair, Nails Culture)
• DES  (See: Cardiomyopathy Gene Analysis)
• Desipramine
• Desoxyn  (See: Methamphetamine)
• Desyrel  (See: Trazodone)
• Dexamethasone Suppresson Test  (See: Cortisol)
• Dextromethorphan and Metabolite, Urine
• DFNB4  (See: Pendred Syndrome Gene Sequencing)
• DFNB4 Syndrome  (See: Pendred Syndrome Gene Sequencing)
• DGS2  (See: Cardiomyopathy Gene Analysis)
• DHCR7  (See: Holoprosencephly Gene Evaluation)
• DHEA  (See: Dehydroepiandrosterone)
• DHEA Sulfate
• DHEA Sulfate, Immunoassay-Pediatric
• DHEA Unconjugated  (See: Dehydroepiandrosterone)
• DHEAS  (See: DHEA Sulfate)
• DHH  (See: Disorders of Sexual Development Gene Analysis)
• DHT  (See: 5-a-Dihydrotestosterone)
• Diacetylmorphine  (See: Heroin, Confirmation)
• Diagnostic Pap  (See: Cytology, Diagnostic Thin Layer Cervical-Vaginal Pap Test With Guided Screening)
• Diagnostic Pap  (See: Cytology, Diagnostic Thin Layer Cervical-Vaginal Pap Test (Fairview Range only))
• Diagnostic Pap  (See: Cytology, Diagnostic Thin Layer Cervical Vaginal Pap Test, Grand Itasca)
• Dialysis Water Culture
• Diamorphine  (See: Heroin, Confirmation)
• Diamox  (See: Acetazolamide)
• Diazepam (Valium)  (See: Drug Confirmatory Panel, Urine)
• Diff  (See: WBC Count and Differential)
• Differential Leukocyte Count  (See: WBC Differential Count)
• Diffuse Large B Cell Lymphoma (DLBCL) NGS Panel
• Diflucan  (See: Fluconazole)
• Digibind, Free  (See: Digoxin, Free - LG3187)
• Digoxin Level
• Digoxin, Free - LG3187
• Digoxin, Unbound  (See: Digoxin, Free - LG3187)
• DIGX  (See: Digoxin Level)
• Dihydrocodeine  (See: Drug Confirmatory Panel, Urine)
• Dihydromorphinone  (See: Hydromorphone, GC/MS Confirmation)
• Dihydropryimidine Dehydrogenase (DPYD), 3 Variants - LG5605
• Dihydropteridine Reductase (DHPR) Deficiency
• Dihydropteridine Reductase (DHPR) Deficiency - LG4255
• Dihydrotestosterone Sulfate  (See: 5-a-Dihydrotestosterone)
• Dilantin  (See: Phenytoin Level, Grand Itasca)
• Dilantin  (See: Phenytoin, Free)
• Dilantin  (See: Phenytoin Level)
• Dilaudid  (See: Hydromorphone, GC/MS Confirmation)
• Diphenhydramine
• Diphenhydramine (Benadryl), Urine
• Diphenylhydantoin  (See: Phenytoin Level)
• Diphenylhydantoin  (See: Phenytoin Level, Grand Itasca)
• Diphtheria and Tetanus Antibody
• Diphtheria and Tetanus Antibody - Cancel and reorder as ARMISC LG423
• Diphtheria Antibody  (See: Diphtheria and Tetanus Antibody - Cancel and reorder as ARMISC LG423)
• Diphtheria Antibody
• Diphtheria Antibody - Cancel and reorder as ARMISC, LG3909
• Diphtheria Culture  (See: Corynebacterium diphtheriae Culture)
• Dipropylacetic Acid  (See: Valproic Acid, Grand Itasca)
• Dipropylacetic Acid  (See: Valproic Acid)
• Direct Antiglobulin Test
• Direct Antiglobulin Test, UMMC-University, Northland and Range Only
• Direct Antiglobulin Test, UMMC-University, Northland, Range and Grand Itasca Only
• Direct Coombs  (See: Direct Antiglobulin Test, UMMC-University, Northland, Range and Grand Itasca Only)
• Direct Coombs' Test  (See: Direct Antiglobulin Test)
• Direct Dialysis (Triiodothyronine, Free by Equilibrium Dialysis/HPLC-Tandem Mass Spectrometry)  (See: Thyroxine, Free by Equilibrium Dialysis)
• Direct EIA  (See: RSV Rapid Antigen)
• Direct Immunofluorescent stain/stains DIF - LG6195
• Direct Platelet Antibody  (See: Platelet Associated Immunoglobulins, Qualitative)
• Direct Platelet Antibody Screen  (See: Platelet Associated Immunoglobulins, Qualitative)
• Direct Platelet Associated Antibody  (See: Platelet Associated Immunoglobulins, Qualitative)
• Direct Thrombin Inhibitor Assay  (See: Argatroban Assay)
• Disaccharidase, Tissue
• Disopyramide
• Disopyramide Unbound  (See: Disopyramide, Free)
• Disopyramide, Free
• Disorders of Sexual Development Gene Analysis
• DISP1  (See: Holoprosencephly Gene Evaluation)
• Diuretic Screen, Urine
• D-Lactate, Plasma
• DLG3  (See: X-Linked Intellectual Disability Gene Analysis)
• DLL1  (See: Holoprosencephly Gene Evaluation)
• DM, Methorphan  (See: Dextromethorphan and Metabolite, Urine)
• DM1 DNA Test
• DM2 (CNBP) DNA Test
• DMD  (See: Cardiomyopathy Gene Analysis)
• DMP1 Gene Sequencing  (See: Hypophosphatemic Rickets Evaluation)
• DMPK DNA Test  (See: DM1 DNA Test)
• DNA Antibodies
• DNA BANKING Prevention 500 - LG5651
• DNA Binding  (See: DNA Antibodies)
• DNA Cell Cycle Analysis Ploidy and S-Phase - LG761
• DNA Marker Engraftment, Graft vs Host
• DNA Marker Engraftment, Graft vs Host
• DNA Marker, Post BMT Engraftment, Blood
• DNA Marker, Post BMT Engraftment, Blood
• DNA Marker, Post BMT Engraftment, Bone Marrow
• DNA Marker, Post BMT Engraftment, Tissue
• DNA Marker, Pre BMT Engraftment, Recipient Testing
• DNA Marker, Pre BMT Engraftment, Recipient Testing
• DNA Marker, Pre-BMT Engraftment Donor Testing
• DNA Molecular Banking - no longer available
• DNA Polymorphism  (See: DNA Marker, Pre-BMT Engraftment Donor Testing)
• DNA Polymorphism  (See: DNA Marker, Pre BMT Engraftment, Recipient Testing)
• DNAJC19  (See: Cardiomyopathy Gene Analysis)
• DNase Antibody  (See: DNase B Antibodies)
• DNase B Antibodies
• DNMT3A  (See: Myelodysplastic Syndrome Focused NGS Panel)
• DOC  (See: Deoxycorticosterone, Pediatric)
• DOCK8 Duplication and Deletion  (See: Hyper-IgE Syndrome Gene Analysis)
• DOCK8 Gene Sequencing  (See: Hyper-IgE Syndrome Gene Analysis)
• DOCK8 Known Mutation  (See: Hyper-IgE Syndrome Gene Analysis)
• Dog  (See: Allergy Pediatric March Profile IgE)
• Dog Epithelium  (See: Allergen: Inhalants, Environmental Profile 10 - LG5471)
• Dolophine  (See: Methadone, Serum - LG1451)
• Dominant Charcot-Marie-Tooth  (See: Charcot Marie Tooth (CMT) Evaluation)
• Donor Engraftment involved in GVH Disease  (See: DNA Marker Engraftment, Graft vs Host)
• Dopamine, Plasma  (See: Catecholamines Fractionated, Plasma (Epinephrine, Norepinephrine and Dopamine))
• Double-Stranded DNA Antibodies  (See: DNA Antibodies)
• Downs  (See: Non-Invasive Prenatal Test Cell Free DNA)
• Downs Syndrome  (See: First Trimester Screen Biochemistry Markers)
• Doxepin and Desmethydoxepin
• DQ*06  (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
• DQ06  (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
• DQB1*06:02  (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
• DQB1-06:02  (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
• DQB1-0602  (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
• DR15  (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
• DR2  (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
• DRPLA (ATN1) Repeat Expansion DNA Test
• Drug Abuse  (See: Drug Screen, Comprehensive with Reported Medications, Whole Blood)
• Drug Abuse Screen 1, Urine (ER)
• Drug Abuse Screen 1, Urine (ER)
• Drug Abuse Screen 4, Urine (Chem Dep)
• Drug Abuse Screen 4, Urine (Chem Dep)
• Drug Abuse Screen 6, Urine (Chem Dep)
• Drug Abuse Screen 6, Urine (Chem Dep)
• Drug Abuse Screen 7, Urine (Perinatal/Newborn)
• Drug Abuse Screen 7, Urine (Perinatal/Newborn)
• Drug Abuse Screen 77, Urine
• Drug Abuse Screen 8, Urine
• Drug Abuse Screen 8, Urine
• Drug Abuse Screen, Serum
• Drug Abuse Screen, Urine - CUHCC Clinic Only
• Drug Abuse Screen, Urine - CUHCC Clinic Only
• Drug Confirmatory Panel, Urine
• Drug Dependent Platelet Antibody  (See: Platelet Antibody, Drug Dependent)
• Drug Detection Panel, Umbilical Cord, Qualitative
• Drug Induced SLE  (See: Histone Antibody, IgG)
• Drug Screen  (See: Drugs of Abuse Screen, Urine, Grand Itasca)
• Drug Screen 8 with Reflex to Confirmation, Serum - LG6856
• Drug Screen Comprehensive, Serum or Plasma
• Drug Screen, Comprehensive with Reported Medications, Whole Blood
• Drug Screen, Gastric, Qualitative
• Drug Screen, Meconium 10 Panel
• Drug Screen, Meconium 5 Panel
• Drug Screen, Serum/Plasma
• Drug-Dependent RBC Antibody Study - LG5668
• Drugs of Abuse Screen, Urine, Grand Itasca
• Drugs of Abuse Screen, Urine, Point of Care
• DSC2  (See: Cardiomyopathy Gene Analysis)
• DSD  (See: Disorders of Sexual Development Gene Analysis)
• dsDNA Antibodies  (See: DNA Antibodies)
• DSP  (See: Cardiomyopathy Gene Analysis)
• DSP  (See: Epidermolysis Bullosa Gene Analysis)
• Dual Genome Panel by Massively Parallel Sequencing
• Duchene Muscular Dystrophy Single Exon Sequencing Known Mutation - LG6118
• Duchenne Muscular Dystrophy, Deletion/Duplication Analysis only - LG5513
• Duchenne Muscular Dystrophy, Female Carrier Testing for Deletion and Duplication - LG5638
• Duchenne Muscular Dystrophy, Stepwise Mutation Deletion Analysis - LG5513
• Duchenne Muscular Dystrophy, Stepwise Mutation Deletion and Sequencing - LG5514
• Duramorph  (See: Morphine, Serum or Plasma)
• Dust  (See: Allergy Pediatric March Profile IgE)
• Dx XomeDx - Whole Exome Sequencing (Proband)  (See: XomeDx to GeneDx - LG6585)
• d-Xylose Absorption Test, Blood (25 g dose)  (See: Xylose Absorption Test, Blood & Urine (Adult 25 g dose) - LG4069)
• Dysgenesis  (See: Neuropathy Gene Analysis)
• Dysmorphic Erythrocytes, Urine  (See: RBC Morphology Evaluation in Urine)
• Dysmorphic RBC, Urine  (See: RBC Morphology Evaluation in Urine)
• Dystrophin Gene Direct Sequencing Analysis - LG5646